Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $2,679 - $3,209
20 Added 20.41%
118 $17,000
Q3 2022

Nov 01, 2022

SELL
$126.59 - $161.18 $2,531 - $3,223
-20 Reduced 16.95%
98 $13,000
Q4 2021

Feb 08, 2022

BUY
$119.87 - $145.67 $4,195 - $5,098
35 Added 42.17%
118 $15,000
Q3 2020

Nov 03, 2020

BUY
$105.46 - $144.13 $1,054 - $1,441
10 Added 13.7%
83 $12,000
Q3 2019

Nov 08, 2019

BUY
$125.18 - $143.24 $1,877 - $2,148
15 Added 25.86%
73 $9,000
Q1 2019

Apr 30, 2019

BUY
$121.81 - $142.95 $2,436 - $2,859
20 Added 52.63%
58 $8,000
Q4 2018

Feb 11, 2019

BUY
$115.94 - $166.74 $4,405 - $6,336
38 New
38 $5,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Lee Financial CO Portfolio

Follow Lee Financial CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

News

Stay updated on Lee Financial CO with notifications on news.